MedTrace Logo

Ten-Year Outcomes of Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease

NCT05125367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 880

Last updated 2022-08-05

No results posted yet for this study

Summary

The primary objective of the BEST extended 10Y follow-up study is to compare the safety and effectiveness of coronary stent implantation using everolimus-eluting balloon-expandable stents with bypass grafting for the treatment of multivessel coronary artery disease at minimum of 10 years follow-up.

Conditions

  • Multivessel Coronary Artery Disease

Interventions

PROCEDURE

coronary stent implantation

coronary stent implantation using everolimus-eluting balloon expandable stents

PROCEDURE

bypass grafting

coronary artery bypass graft

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Seung-Jung Park

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • China
  • Malaysia
  • South Korea
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05125367 on ClinicalTrials.gov